All hospitals may request a backup controller with modified software for the Heartware Ventricular Assist Device System to use in certain circumstances if the primary controller fails to restart the pump, the Food and Drug Administration announced today. Medtronic last year recalled over 1,600 of the devices because the internal pump may stop and fail to restart, among other safety concerns, but said the risk of removing an implanted device may outweigh the benefits.

Related News Articles

Headline
The Government Accountability Office Dec. 21 recommended the Food and Drug Administration and Cybersecurity and Infrastructure and Security Agency update a 5-…
Headline
The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device…
Headline
On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a webinar to review its recent proposed rule for laboratory developed tests,…
Headline
The Food and Drug Administration the week of Aug. 7 cleared for marketing the first sterilization system for 3D-printed devices in health care facilities. The…
Headline
The Environmental Protection Agency today proposed requiring commercial sterilization facilities to comply within 18 months with stricter emission and…
Headline
Effective today under the Consolidated Appropriations Act of 2023, medical devices seeking approval from the Food and Drug Administration must meet certain…